Innovara Revenue and Competitors
Estimated Revenue & Valuation
- Innovara's estimated annual revenue is currently $6.6M per year.
- Innovara's estimated revenue per employee is $201,000
Employee Data
- Innovara has 33 Employees.
- Innovara grew their employee count by 6% last year.
Innovara's People
Name | Title | Email/Phone |
---|---|---|
1 | Director, Medical & Scientific Affairs | Reveal Email/Phone |
2 | Director, Global Learning and Development | Reveal Email/Phone |
3 | Owner | Reveal Email/Phone |
Innovara Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $413.3M | 324 | 0% | $634M | N/A |
#2 | $47.8M | 238 | 0% | N/A | N/A |
#3 | $2.4M | 12 | -52% | N/A | N/A |
#4 | $25.7M | 128 | 39% | N/A | N/A |
#5 | $12.9M | 64 | 129% | N/A | N/A |
#6 | $23.9M | 119 | 8% | $113M | N/A |
#7 | $0.3M | 3 | 0% | N/A | N/A |
#8 | $10.3M | 51 | -14% | N/A | N/A |
#9 | $1.8M | 367 | -4% | $538M | N/A |
#10 | $50M | 249 | 3% | N/A | N/A |
What Is Innovara?
Innovara, Inc. is a global business and management development company that works with pharmaceutical and other healthcare industry clients around the world to improve their sales, marketing, and management performance. We provide highly customized training, medical thought leadership services, as well as strategy and business development services for the healthcare, pharmaceutical, biotechnology, and medical device industries. Innovara provides services around the world with trainers and consultants located in Argentina, Australia, China, Canada, Egypt, India, Indonesia, Japan, South Korea, Taiwan, Thailand, Turkey, sub-Saharan Africa, and the USA.
keywords:N/AN/A
Total Funding
33
Number of Employees
$6.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $12.7M | 58 | -3% | N/A |
#2 | $11.8M | 64 | 7% | N/A |
#3 | $21.4M | 102 | 10% | N/A |
#4 | $25.1M | 114 | -3% | N/A |
#5 | $25.4M | 165 | 7% | N/A |